Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STROKE34 intra-arterial CD34+ cells in acute ischemic stroke
2017-002456-88Phase 2Active
- Sponsor
- Centro Hospitalar e Universitário de Coimbra
- Start
- Jan 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised trial of autologous CD34+ cells in ischemic stroke (2 arms), sponsored by Centro Hospitalar e Universitário de Coimbra. Primary endpoint: Ischemic stroke volume on MRI at 3 months. Started Jan 2020; status: active.
02
Drugs
autologous CD34+ cells
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2017-002456-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002456-88.